Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry

Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry

Abstract Background Achieving and maintaining a low-risk profile is associated with favorable outcome in pulmonary arterial hypertension (PAH). The effects of treatment on risk profile are variable among patients. Objective To Identify variables that might predict the response to treatment with phos...

Full description

Bibliographic Details
Main Authors: Agustin R. Garcia, Isabel Blanco, Lluis Ramon, Jesús Pérez-Sagredo, Francisco J. Guerra-Ramos, Clara Martín-Ontiyuelo, Olga Tura-Ceide, Francisco Pastor-Pérez, Pilar Escribano-Subías, Joan A. Barberà
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Respiratory Research
Subjects:
Pulmonary arterial hypertension
Vasodilator agents
Phosphodiesterase-5 inhibitors
Sildenafil citrate
Tadalafil
Treatment outcome
Online Access:https://doi.org/10.1186/s12931-023-02531-1

Internet

https://doi.org/10.1186/s12931-023-02531-1

Similar Items